Sunday - April 27, 2025

LOGIN  |  REGISTER
Assertio
Assertio

Astrana Health to Participate in Upcoming Investor Conferences

May 28, 2024 | Last Trade: US$30.60 0.80 -2.55

ALHAMBRA, Calif., May 28, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the following upcoming investor conferences:

  • The Leerink Healthcare Crossroads Conference, being held in Austin, on Wednesday, May 29, 2024, including a fireside chat at 1:00pm CT.
  • The William Blair 44th Annual Growth Stock Conference, being held in Chicago, on Wednesday, June 5, 2024, including a presentation at 4:40pm CT. The webcast link will be available at the "IR Calendar" section of the Company's website: https://ir.astranahealth.com/news-events/ir-calendar.
  • The Truist Healthcare Disruptors & Digital Health Summit, being held in New York, on Tuesday, June 25, 2024, including a panel presentation at 3:30pm ET.

About Astrana Health, Inc.

Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

Headquartered in Alhambra, California, Astrana serves over 10,000 providers and 1 million Americans in value-based care arrangements. Its subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), accountable care organizations (ACOs), and care delivery entities across primary, multi-specialty, and ancillary care. For more information, please visit www.astranahealth.com.

FOR MORE INFORMATION, PLEASE CONTACT:
Investor Relations
(626) 943-6491
investors@astranahealth.com

Asher Dewhurst, ICR Westwicke
investors@astranahealth.com

Chimerix

Stock Quote

Featured Stock

Astria Therapeutics

Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page